• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Aminoquinolines and derivatives

Research Brief on 6-Fluoro-4-(trifluoromethyl)quinolin-2-amine (CAS: 1116339-59-3): Recent Advances and Applications

The compound 6-Fluoro-4-(trifluoromethyl)quinolin-2-amine (CAS: 1116339-59-3) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and emerging roles in drug discovery. Recent studies highlight its utility as a key intermediate in the development of novel kinase inhibitors and antimicrobial agents, with particular emphasis on its mechanism of action and structure-activity relationships (SAR).

Recent publications in journals such as the Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters have explored the synthetic pathways for 6-Fluoro-4-(trifluoromethyl)quinolin-2-amine, emphasizing its efficient preparation via palladium-catalyzed cross-coupling reactions. The compound's fluorine and trifluoromethyl groups are noted for enhancing metabolic stability and binding affinity, making it a promising scaffold for targeting protein kinases involved in cancer and inflammatory diseases. Computational modeling studies further support its potential as a selective inhibitor of EGFR and JAK2 kinases, with in vitro assays demonstrating sub-micromolar IC50 values.

In addition to its kinase inhibitory properties, 6-Fluoro-4-(trifluoromethyl)quinolin-2-amine has shown notable antimicrobial activity against drug-resistant bacterial strains, including MRSA and Pseudomonas aeruginosa. A 2023 study published in Antimicrobial Agents and Chemotherapy revealed that derivatives of this compound disrupt bacterial biofilm formation, suggesting a novel mechanism distinct from traditional antibiotics. These findings underscore its dual potential as both an anticancer and anti-infective agent, warranting further preclinical evaluation.

The compound's pharmacokinetic profile has also been investigated in recent rodent models, with results indicating favorable oral bioavailability (～65%) and a half-life of 4.2 hours. However, challenges remain in optimizing its blood-brain barrier penetration for CNS-targeted applications. Collaborative efforts between academia and industry (e.g., patent WO2023015126) are currently exploring prodrug strategies to address this limitation while maintaining the core quinoline pharmacophore.

In conclusion, 6-Fluoro-4-(trifluoromethyl)quinolin-2-amine represents a versatile chemical entity with multifaceted therapeutic potential. Ongoing research is expected to elucidate its full spectrum of biological activities and refine its structural derivatives for clinical translation. This brief highlights the imperative for interdisciplinary collaboration to harness this compound's capabilities in addressing unmet medical needs.

• 211449-19-3(4-(Trifluoromethyl)quinolin-2-amine)
• 1357945-83-5(8-(trifluoromethyl)isoquinolin-3-amine)
• 1431426-58-2(5,7-Bis(trifluoromethyl)quinolin-2-amine)
• 1357947-16-0(8-(Trifluoromethyl)isoquinolin-1-amine)
• 1357946-73-6(5-(trifluoromethyl)isoquinolin-3-amine)
• 791595-93-2(6-(trifluoromethyl)quinolin-2-amine)
• 651055-83-3(6-Phenanthridinamine, 8-(trifluoromethyl)-)
• 1307238-26-1(6-fluoro-4-methylquinolin-2-amine)
• 1782359-42-5(7-fluoro-4-methylquinolin-2-amine)
• 113508-12-6(7-(trifluoromethyl)quinolin-2-amine)